key: cord-0838598-7bh6vjzv
authors: Birabaharan, Morgan; Kaelber, David C.; Karris, Maile Y.
title: Risk of Herpes Zoster Reactivation After mRNA COVID-19 Vaccination: A Cohort Study
date: 2021-11-23
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2021.11.025
sha: 5c4075bf824f6d557b99b3cd0fb084b434832dc1
doc_id: 838598
cord_uid: 7bh6vjzv

nan

Recent case series and media coverage suggest an association between receiving the mRNA 39 COVID-19 vaccine and reactivation of varicella zoster virus (VZV) [1] [2] [3] . Fear of a potential 40 adverse effect will drive vaccine refusal and subsequent preventable disease and death. The 104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130  131  132 J o u r n a l P r e -p r o o f 

Cutaneous reactions reported after 91

Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory 95 rheumatic diseases: a case series

Varicella-zoster virus reactivation 97 after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases

Herpes zoster and postherpetic 100 neuralgia surveillance using structured electronic data

Seasonal variation in herpes zoster infection